Author

Alexander E Kel

GeneXplain (Germany)ORCID 0000-0001-6775-2467Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Barry James CampbelliD· 1 shared Carrie A. DuckworthiD· 1 shared Chris Probert· 1 shared David G. SpilleriD· 1 shared David Mark PritchardiD· 1 shared Emily Smith· 1 shared François BergeyiD· 1 shared Hazel EnglandiD· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSystems Biology

Barry James CampbellORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Identification of a novel therapeutic agent for Inflammatory Bowel Disease guided by systems medicine

Katie Lloyd, Stamatia Papoutsopoulou, Emily Smith, Philip Stegmaier, François Bergey, Lorna Morris, Madeleine Kittner, Hazel England, David G. Spiller, Michael White, Carrie A. Duckworth, Barry James Campbell, Vladimir Poroikov, Vítor A. P. Martins dos Santos, Alexander E Kel, , Michael David Burkitt

This study identifies clarithromycin as a potential therapeutic for inflammatory bowel disease through in-silico drug repositioning and experimental validation of its effects on NF-κB signaling.

Disease Models & Mechanisms · Sep 21, 2020Peer-reviewedSystems Biology